Ghrelin-receptor GHRP appetite-driving GH pulse empty-stomach timing ~100 mcg GHRP selective GH release 23x daily 100300 mcg GHRH analog long-acting 12x weekly 12 mg GHRH analog short-acting 23x daily 100 mcg GHRH analog historical FDA approval daily 200300 mcg GHRH analog FDA-approved (lipodystrophy) daily 2 mg Growth factor preclinical daily 2050 mcg Immune & Immunomodulatory Peptides Compounds in this category are discussed for immune coordination, inflammatory balance, and adjunctive immune support
TAKE TIME OBSERVE LABEL DIRECTIONS
The most common adverse events were mild-to-moderate headaches, similar in frequency to placebo groups
PubMed Kim, S.B., Kwon, D.R., Kwak, H., Shin, Y.B., Han, H.J., Lee, J.H., & Choi, S.H